Sonitus Medical, BHM Partner on Bone Conduction Products
Summary:Sonitus Medical and BHM have formed a strategic partnership to globally commercialize...
Summary:Sonitus Medical and BHM have formed a strategic partnership to globally commercialize...
Cochlear Limited (ASX: COH) announced that it has obtained Food and Drug Administration (FDA) approval and clearance in the last month for its Cochlear Remote Assist solution in the Nucleus and Baha Systems.
Through the annual awards program, HHTM recognizes technological innovation and achievement in the hearing industry. This year’s awards program saw dozens of innovative technologies, submitted from companies across the globe.
The approval of the Cochlear Nucleus Kanso 2 Sound Processor, Nucleus 7 Sound Processor for Nucleus 22 Implant recipients, and Custom Sound Pro fitting software reflects Cochlear’s “ongoing commitment to innovation in hearing technology, providing access to smartphone connectivity and helping to improve hearing performance, and enhancing the cochlear implant fitting experience for hearing health professionals.”
Read MoreIf approved by the FDA, the Acclaim would be the “first-of-its-kind cochlear implant without any external components to offer unique benefits to users and hopefully increase cochlear implant adoption and user compliance across the globe.”
Read MoreMED-EL USA announced the launch of the BCI 602, the second-generation implant for the BONEBRIDGE...
Read MoreCROS and BiCROS hearing aids are not the only treatment options for those with unilateral hearing loss. This article reviews other options and potential future avenues for unilateral sensorineural hearing loss and single-sided deafness, as well as for unilateral conductive hearing loss.
Read MoreImproved modeling for speech and music transduction could boost the performance of cochlear implants.
Read MorePonto 4 is reportedly “the smallest bone anchored device on the market,” according to Oticon, who says it’s 27% smaller than Ponto 3.
Read MoreThe Nucleus Profile Plus Series Cochlear Implant will be commercially available later this month. The Nucleus Profile Plus Series Cochlear Implant is still awaiting approval by Health Canada.
Read MoreAccording to AB, the Ultra 3D multi-magnet assembly is capable of aligning with the magnetic field of the MRI scanner irrespective of patient orientation or movement.
Read MoreThe book describes major advances in our understanding of the pathogenic processes underlying various forms of hearing loss and the emergence of treatments for deafness.
Read MorePonto 4 will officially launch in the US in early summer 2019.
Read MoreHear the World Foundation has partnered with the Global Foundation for Children with Hearing Loss to provide 10 children with CIs, support, and service.
Read MoreThe app is said to guide patients to experience different listening situations, from quiet home settings to more demanding environments, like restaurants, and rate their hearing experience.
Read MoreResearchers from Ann & Robert H. Lurie Children’s Hospital of Chicago present further evidence that deaf children who received cochlear implants (implanted electronic hearing device) before 12 months of age learn to more rapidly understand spoken language and are more likely to develop spoken language as their exclusive form of communication.
Read MoreChildren currently receive the same type of cochlear implant programming as adults even though a child’s ability to process speech information and discriminate pitch is much less developed.
Read MoreImplant users filled out a survey regarding their quality of life that asked questions about social interaction and self-esteem, among others. Those who had correctly identified more emotional utterances were found to also report better quality of life.
Read More